Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Experts Advise Caution Following Study Indicating Testosterone Therapy May Treat Depression In Men November 19, 2018 Irvin Jackson Add Your Comments While new research suggests that testosterone therapy could be used to treat depression in men, some experts are urging the use of caution in interpreting those results. In a study published in JAMA Psychiatry on November 14, German researchers report that testosterone replacement therapy was linked to a significant reduction in symptoms of depression among men, particularly among those who received higher doses. However, in an editorial published with the findings, researchers from Harvard and Columbia University questioned the quality of the evidence and warned that the side effects of testosterone treatments may outweigh any benefits for treating depression. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The study involved a review and meta-analysis of 27 randomized, placebo-controlled clinical trials (RCTs), involving nearly 2,000 men. The researchers looked at alleviation of depressive symptoms, depression status, age, treatment duration and dosage. According to the findings, men who took testosterone therapy were more than twice as likely to report a decrease in the symptoms of depression than men given a placebo. But the researchers warned that the studies they reviewed were never really meant to specifically examine testosterone’s effects on depression. “Testosterone treatment appears to be effective and efficacious in reducing depressive symptoms in men, particularly when higher-dosage regimens were applied in carefully selected samples,” the researchers concluded. “However, given the heterogeneity of the included RCTs, more preregistered trials are needed that explicitly examine depression as the primary end point and consider relevant moderators.” In an editorial published alongside the study’s findings, Shalendar Bhasin of Harvard Medical School and Brigham and Women’s Hospital in Boston, and Dr. Stuart Seidman from Columbia University in New York, warned that the findings do not include enough high quality evidence to say that testosterone therapy can be used to treat depression with any confidence. “Although this meta-analysis adds to the body of data that testosterone administration may be associated with small improvements in depressive symptoms, we do not know whether these improvements are clinically meaningful,” they wrote. “Furthermore, neither the long-term safety nor the efficacy of testosterone therapy has been established in any depressive disorder. Because some of the adverse effects of testosterone are associated with its dose and on-treatment concentrations, the use of supraphysiologic doses of testosterone could be associated with increased risk of adverse effects and is currently not recommended.” Testosterone Side Effects The findings come following years of concerns that drugs have been over-marketed to men without any real medical need for the treatments, after findings that side effects of the low testosterone drugs may increase the risk of heart attacks, strokes and sudden death for men. While medications like Androgel, Testim and others were originally intended as a “niche” treatment for men suffering from confirmed testosterone deficiency, amid aggressive marketing over the last decades, the drugs grew to generate billions in annual sales. There are currently more than 6,000 Androgel lawsuits and other claims pending against makers of testosterone replacement therapy, alleging that users and the medical community were not adequately warned about the potential health risks, including an increased risk of heart attack, stroke, pulmonary embolism, deep vein thrombosis, blood clots and other life-threatening health problems. Many of those cases are expected to be resolved through testosterone settlements reached in agreements over the summer. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: AndroGel, Clinical Trials, Depression, Heart Attack, Stroke, Testosterone Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 5 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 6 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 5 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 6 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)